Apoteksgruppen i Örebro Nr 4 ABActive
Key figures
Key figures
2025Balance structure
Dividend
from the annual reportProposed dividend 500 000 kr.
Summary of annual reports2021–2025
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Balance sheet — assets | |||||
| Total current assets | 5 400 551 | 6 036 505 | 6 716 914 | 8 307 060 | 8 155 761 |
| Total non-current assets | 364 030 | 258 104 | 152 178 | 85 417 | 60 417 |
| Total assets | 5 764 581 | 6 294 609 | 6 869 092 | 8 392 477 | 8 216 000 |
| Balance sheet — liabilities and equity | |||||
| Current liabilities | 3 776 992 | 3 869 034 | 4 105 306 | 4 798 708 | 4 639 293 |
| Non-current liabilities | — | — | — | — | — |
| Total liabilities | 3 776 993 | 3 869 035 | 4 105 306 | 4 798 708 | 4 639 115 |
| Share capital | 100 000 | 100 000 | 100 000 | 100 000 | 100 000 |
| Retained earnings of previous periods | — | — | — | — | — |
| Profit for the year (equity) | 511 110 | 437 986 | 538 211 | 1 129 983 | 583 116 |
| Total equity | 1 987 588 | 2 425 574 | 2 763 786 | 3 593 769 | 3 576 885 |
| Income statement | |||||
| Sales revenue | 21 503 562 | 24 092 194 | 29 234 685 | 33 111 157 | 33 904 000 |
| Operating profit | 670 377 | 576 643 | 701 578 | 1 442 158 | 749 871 |
| EBITDA | 751 303 | 657 569 | 782 504 | 1 483 919 | 749 871 |
| Profit before income tax | 645 654 | 553 446 | 680 565 | 1 424 899 | 738 135 |
| Profit for the reporting year | 511 110 | 437 986 | 538 211 | 1 129 983 | 583 116 |
| Labour costs | 2 497 450 | 2 517 033 | 2 591 629 | 2 623 710 | 3 441 156 |
| Depreciation of non-current assets | 80 926 | 80 926 | 80 926 | 41 761 | 0 |
| Other indicators | |||||
| Employees | 4 | 4 | 3 | 3 | 5 |
| Proposed dividend | — | 200 000 | 300 000 | 600 000 | 500 000 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Similar companies
Summary: Apoteksgruppen i Örebro Nr 4 AB
Overview
Apoteksgruppen i Örebro Nr 4 AB (org. no. 559190-8685) is a limited company (AB). The company was registered in 2019 and has existed for 7 years. Registered seat: Örebro. Industry according to Statistics Sweden: retail sale of pharmaceutical products in specialised stores (SNI 47731).
Economy
Net sales in financial year 2025 were 33 904 000 kr, up 2,4 % on the previous year (33 111 157 kr). From 2021 to 2025, net sales grew by an average of 12,1 % per year. This is the highest net sales among the reported years (2021–2025). Net profit for 2025 was 583 116 kr (1,7 % of net sales). The company was profitable in all 5 reported financial years. Employees in financial year 2025: 5 (previous year: 3). Net sales per employee were 6 780 800 kr. At the end of financial year 2025, total assets were 8 216 000 kr and equity 3 576 885 kr (equity ratio 43,5 %). The annual report for 2025 proposes a dividend of 500 000 kr.
Sources and freshness
Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by 3 people. Data as of 2026-10-19. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.